Results 41 to 50 of about 1,690 (172)

Targeting Features of the Metabolic Syndrome Through Sympatholytic Effects of SGLT2 Inhibition [PDF]

, 2022
Lakshini Y. Herat, Jennifer Matthews, Omar Azzam, Markus P. Schlaich, Vance B. Matthews   +4 more
openalex   +1 more source

Long‐Term Electrocardiographic Changes Following Renal Denervation—Left Ventricular Mass and Arrhythmia Burden

The Journal of Clinical Hypertension, Volume 27, Issue 8, August 2025.
ABSTRACT Renal denervation (RDN) is an adjunct therapy for resistant hypertension, reducing blood pressure (BP) by inhibiting both afferent sensory and efferent sympathetic renal nerve activity. The resulting reduction in central sympathetic outflow including that directed toward the heart may beneficially impact cardiac remodeling, left ventricular ...
Gianni Sesa‐Ashton, Janis M. Nolde, Bart Tang, Revathy Carnagarin, Elisabeth A. Lambert, Gavin W. Lambert, Marcio G. Kiuchi, Vaughan G. Macefield, Antony Walton, Carl J. Schultz, Sharad Shetty, Murray D. Esler, Markus P. Schlaich   +12 more
wiley   +1 more source

Central sympatholytic drugs.

Journal of clinical hypertension (Greenwich, Conn.), 2012
•  Central sympatholytic drugs reduce blood pressure mainly by stimulating central α(2) -adrenergic receptors in the brainstem centers, thereby reducing sympathetic nerve activity and neuronal release of norepinephrine to the heart and peripheral circulation.
Wanpen, Vongpatanasin, Kazuomi, Kario, Steven A, Atlas, Ronald G, Victor   +3 more
openaire   +1 more source

Outcomes Following Radiofrequency Renal Denervation According to Antihypertensive Medications: Subgroup Analysis of the Global SYMPLICITY Registry DEFINE. [PDF]

Hypertension, 2023
Mahfoud F, Mancia G, Schmieder RE, Ruilope L, Narkiewicz K, Schlaich M, Williams B, Ribichini F, Weil J, Almerri K, Sharif F, Lauder L, Wanten M, Fahy M, Böhm M.   +14 more
europepmc   +1 more source

Sympatholytic effect of intravascular ATP is independent of nitric oxide, prostaglandins, Na⁺/K⁺‐ATPase and K_IR channels in humans [PDF]

, 2017
Christopher M. Hearon, Jennifer C. Richards, Mathew L. Racine, Gary J. Luckasen, Dennis G. Larson, Michael J. Joyner, Frank A. Dinenno   +6 more
openalex   +1 more source

Reversal of the Sedative and Sympatholytic Effects of Dexmedetomidine with a Specific α2-Adrenoceptor Antagonist Atipamezole [PDF]

, 1998
Harry Scheinin, Riku Aantaa, Markku Anttila, P Hakola, Antti Helminen, Sakari Karhuvaara   +5 more
openalex   +1 more source

ACE inhibition: Postsynaptic adrenergic sympatholytic action in man [PDF]

, 1997
D. Lyons
openalex   +1 more source

Analgesic and sympatholytic effects of low-dose intrathecal clonidine compared with bupivacaine: a dose–response study in female volunteers [PDF]

, 2013
Yehuda Ginosar, Edward T. Riley, Martin S. Angst   +2 more
openalex   +1 more source

Autonomic Testing Optimizes Therapy for Heart Failure and Related Cardiovascular Disorders. [PDF]

Curr Cardiol Rep, 2022
DePace NL, Colombo J, Mandal K, Eisen HJ.   +3 more
europepmc   +1 more source

Predicting Peri-intubation Cardiovascular Instability: Preintubation Vital Signs Are Vital. [PDF]

Am J Respir Crit Care Med, 2023
Leisman DE, Crowley JC.
europepmc   +1 more source